Article abstract


Nature Medicine 13, 1476 - 1482 (2007)
Published online: 2 December 2007 | doi:10.1038/nm1669

Antidepressant actions of the exercise-regulated gene VGF

Joshua G Hunsberger1, Samuel S Newton1, Alicia H Bennett1, Catharine H Duman1, David S Russell1, Stephen R Salton2 & Ronald S Duman1


Exercise has many health benefits, including antidepressant actions in depressed human subjects, but the mechanisms underlying these effects have not been elucidated. We used a custom microarray to identify a previously undescribed profile of exercise-regulated genes in the mouse hippocampus, a brain region implicated in mood and antidepressant response. Pathway analysis of the regulated genes shows that exercise upregulates a neurotrophic factor signaling cascade that has been implicated in the actions of antidepressants. One of the most highly regulated target genes of exercise and of the growth factor pathway is the gene encoding the VGF nerve growth factor, a peptide precursor previously shown to influence synaptic plasticity and metabolism. We show that administration of a synthetic VGF-derived peptide produces a robust antidepressant response in mice and, conversely, that mutation of VGF in mice produces the opposite effects. The results suggest a new role for VGF and identify VGF signaling as a potential therapeutic target for antidepressant drug development.

Top
  1. Department of Psychiatry, Yale University, 34 Park Street, New Haven, Connecticut 06508 USA.
  2. Fishberg Department of Neuroscience, Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, New York 10029, USA.

Correspondence to: Ronald S Duman1 e-mail: ronald.duman@yale.edu